학술논문

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
Document Type
Article
Source
In: Molecular Therapy. (Molecular Therapy, 1 November 2023, 31(11):3176-3192)
Subject
Language
English
ISSN
15250024
15250016